Press release
Primary Cells Market Size Climbs to a Record $8bn New Players Steams Into the Market ALLCells, Cell Biologics & Promocell - Industry is Projected to Grow at a CAGR Of 9.5% | Forecast to 2023
Market Highlights:
The global primary cells market is expected to grow significantly over the forecast period. It is estimated that the global primary cells market is expected to register a CAGR of ~ 9.5 % during the forecast period, from 2018 to 2023.
Primary human cells are the cells isolated directly from normal human tissues or blood cells via the enzymatic or mechanical method. Primary cells maintain their fundamental cellular functions hence, their use in cell-based research programs is increasing significantly. The rapid growth in biotechnology and biopharmaceutical industries, growing cancer research, increasing demand for monoclonal antibodies, and rising healthcare expenditure are anticipated to drive the growth of the market during the forecast period. Moreover, advantages of primary human cells over cell lines contribute to the growth of the market. For instance, endothelial cell lines, lack various functional markers, whereas primary endothelial cells retain these critical features. Despite these drivers, the high cost of advanced primary cells and risk of contamination may hamper the growth of the global primary cells market during the assessment period.
Get Premium Sample Report @ https://www.marketresearchfuture.com/sample_request/6296
Top Players in Primary Cells Market:
• Lonza (Switzerland)
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Cell Biologics (US)
• Promocell (Germany)
• ZenBio, Inc. (US)
• STEMCELL Technologies (Canada)
• ALLCells (US)
• American Type Culture Collection (ATCC) (US)
• Axol Biosciences (UK)
Market Segmentation of Primary Cells Market:
The global primary cells market has been segmented into origin, type, and end user.
The market on the basis of origin has been segmented into skin cells, hematopoietic cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and others.
The market on the basis of type has been segmented into human primary cells and animal primary cells.
On the basis of end-user, the market has been segmented into research institutes and life science research companies.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The primary cells market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European primary cells market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The primary cells market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The primary cells market in the Middle East and Africa has been segmented into the Middle East and Africa.
Intended Audience:
• Research Laboratories
• Cancer Research Institutes
• Biotechnology and Biopharmaceutical Companies
• Distributors of Primary Cells
• Clinical Research Organizations (CROs)
Regional Analysis of Primary Cells Market:
Geographically, the Americas is anticipated to dominate the global primary cells market. The market growth in this region is attributed to the presence of a well-established healthcare system, increasing prevalence of cancer, growing government funding in research, and technological advancements. According to the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the US in 2016.
Europe is expected to be the second largest in the global primary cells market. It is expected that the government support towards research and development and growing prevalence of chronic diseases such as cancer are likely to drive the market growth in this region. According to the Office for National Statistics, the gross domestic expenditure on Research and Development (R&D) activities was Euro 33.1 billion (USD 35.2 billion) in 2016.
The primary cells market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, and Australia. The market growth is mainly driven by rapidly expanding biopharmaceutical industries in the region, rising prevalence of cancer, growing pharmaceutical outsourcing, and increasing government funding in the life sciences sector. Moreover, countries such as India and China have established research institutes promoting cell-based research which contributes to the market growth.
The Middle East and Africa holds the lowest share of the global market owing to the slow economic development, lack of technical knowledge, and poor medical facilities.
Need More Information Ask to our experts @ https://www.marketresearchfuture.com/enquiry/6296
Major Points form TOC for Primary Cells Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Primary Cells Market, By Type
Chapter 7. Global Primary Cells Market, By Origin
Chapter 8 Global Primary Cells Market, By End User
Chapter 9. Global Primary Cells Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
TOC Continued….!
Get Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/6296
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Cells Market Size Climbs to a Record $8bn New Players Steams Into the Market ALLCells, Cell Biologics & Promocell - Industry is Projected to Grow at a CAGR Of 9.5% | Forecast to 2023 here
News-ID: 1226788 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
